[
    [
        {
            "time": "",
            "original_text": "单日8家IPO公司集体大考！多家公司竟携诉讼闯关 诉讼纠纷",
            "features": {
                "keywords": [
                    "IPO",
                    "诉讼",
                    "纠纷"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "法律"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "单日8家IPO公司集体大考！多家公司竟携诉讼闯关 诉讼纠纷",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "IPO观察｜益方生物零收入闯关，研发费用14亿，专利纠纷缠身",
            "features": {
                "keywords": [
                    "IPO",
                    "益方生物",
                    "零收入",
                    "研发费用",
                    "专利纠纷"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "IPO观察｜益方生物零收入闯关，研发费用14亿，专利纠纷缠身",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]